Loading...
Does route of administration affect the outcome of TNF antagonist therapy?
The tumor necrosis factor (TNF) antagonists are parenterally administered biologic response modifiers indicated for the management of rheumatoid arthritis. Although infliximab, etanercept, and adalimumab are all members of this class, they differ in route of administration and dosing regimen. In the...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2004
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2833461/ https://ncbi.nlm.nih.gov/pubmed/15228617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar996 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|